Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are in good general health and are expected to live more than 10 years
- People whose prostate cancer has come back after having their prostate surgically removed (including those who previously had a second surgery to remove the prostate, or who have had radiation therapy to the prostate area or nearby lymph nodes after their original surgery)
- People whose cancer has spread to no more than 3 lymph nodes on one side of the pelvis, as detected by a specialised scan called a PSMA PET scan
- People whose PSA level (a blood marker for prostate cancer) was below 4 ng/ml at the time of their PSMA PET scan
Who may not be able to join:
- People for whom surgery or a specific type of lymph node removal procedure on both sides of the pelvis would not be safe or suitable
- People whose PSMA PET scan shows signs of cancer returning in the area where the prostate was, or spreading to areas outside the pelvis
- People whose PSMA PET scan was performed more than 4 months before the planned lymph node removal surgery
- People who have received hormone therapy for prostate cancer within the 6 months before joining the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +49 (0) 40 7410 53115
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of complete biochemical response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.